{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-016562","form_type":"8-K","ticker":"RMSL","cik":"0001412126","company_name":"RemSleep Holdings Inc.","filed_at":"2022-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.366851+00:00","generated_at":"2026-06-26T11:50:47.839619+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"RemSleep reports cytotoxicity test failures on DeltaWave cannula; new lab to retest","bullets":["Two cytotoxicity tests on DeltaWave cannula MD, Angled Adaptor and Flexible Hose failed in early 2022.","Superior Toxicology & Wellness concluded original testing protocols were flawed and erroneous.","New third-party lab will conduct cytotoxicity tests with corrected procedures.","Initial tests by Product Safety Labs in New Jersey; both were failures.","CEO Tom Wood received letter from Dr. Joe Nieusma on March 25, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-016562","json":"https://secwatch.observer/filing/0001213900-22-016562.json","markdown":"https://secwatch.observer/filing/0001213900-22-016562.md","text":"https://secwatch.observer/filing/0001213900-22-016562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412126/000121390022016562/0001213900-22-016562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412126/000121390022016562/ea157712-8k_remsleep.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T11:50:47.839619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}